BD Acquires Venclose, Inc. To Extend Treatment Innovations In Chronic Venous Disease
- Thursday, December 2, 2021, 7:04
- Finance
- Add a comment
FRANKLIN LAKES, N.J., Dec. 2, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it has acquired Venclose, Inc., a provider of solutions for the treatment of chronic venous insufficiency (CVI) — a disease that…
About the Author
adminasapcorp has written 41283 stories on this site.